Stocks
Equillium, Inc.EQ
NASDAQHealthcareBiotechnology$2.47+19.32%
A clinical-stage biotechnology company focused on developing immunology therapies for severe autoimmune and inflammatory diseases. Its pipeline centers on targeting immune pathways such as CD6 to treat conditions including graft-versus-host disease and other immune-mediated disorders. With no approv...
Market Cap: $87.7M52W Range: $0.27 – $2.63
This page tracks all publicly disclosed congressional trades in Equillium, Inc. (EQ), a company in the Healthcare sector. All data is sourced from STOCK Act Periodic Transaction Reports filed with the House and Senate disclosure offices.
Total Disclosures
0
Unique Politicians
0
Buys
0
Sells
0
Congressional Trading History
No congressional trades found for this stock.